Combination Reperfusion Therapy with Eptifibatide and Tenecteplase for Acute Myocardial Infarction

Publisher： Karger

E-ISSN： 1424-0556|1|1|5-13

ISSN： 1422-9528

Source： Heart Drug, Vol.1, Iss.1, 2001-03, pp. : 5-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics and Pharmacodynamics of Tenecteplase in Fibrinolytic Therapy of Acute Myocardial Infarction

By Tanswell P.  

Clinical Pharmacokinetics, Vol. 41, Iss. 15, 2002-01 ,pp. : 1229-1245

Adis International

Access to resources Recommend Favorite

Safety and efficacy of tenecteplase in acute myocardial infarction

By Guerra Daniel R   Karha Juhana   Gibson C Michael  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 791-798

Informa Healthcare

Access to resources Recommend Favorite

Tenecteplase: A Review of its Pharmacology and Therapeutic Efficacy in Patients with Acute Myocardial Infarction

By Dunn C.J.   Goa K.L.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 1, 2001-01 ,pp. : 51-66

Adis International

Access to resources Recommend Favorite

New Approaches to Treatment of Acute Myocardial Infarction: Combination Antiplatelet and Fibrinolytic Therapy

By  

Heart Drug, Vol. 2, Iss. 4, 2002-11 ,pp. : 192-200

Karger

Access to resources Recommend Favorite

Optimizing Reperfusion Therapy: Adjunct Use of Glycoprotein IIb/IIIa Antagonists with Fibrinolytic Therapy in Acute Myocardial Infarction

By  

Heart Drug, Vol. 1, Iss. 1, 2001-03 ,pp. : 52-55

Karger

Access to resources Recommend Favorite